Find Research Outputs

Search concepts
Selected filters
2017
7 Citations (Scopus)
2014
361 Citations (Scopus)

Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: The GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab

Stroes, E. S. G., Colquhoun, D. M., Sullivan, D. R., Civeira, F., Rosenson, R. S., Watts, G., Bruckert, E., Cho, L., Dent, R. E., Knusel, B., Xue, A., Scott, R. A. H., Wasserman, S. M. & Rocco, M. B., 2014, In : Journal of the American College of Cardiology. 63, 23, p. 2541-2548

Research output: Contribution to journalArticle

Open Access
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Phase III Clinical Trials
Controlled Clinical Trials
LDL Cholesterol
Cholesterol
2015
4 Citations (Scopus)
Hypertriglyceridemia
Glass
Triglycerides
Pancreatitis
Fasting
2013

Familial hypercholesterolemia:bridging and minding the gap in healthcare.

Pang, J., Vickery, A. & Watts, G., 2013, Advances in Dyslipidemia. Aronow, W. S. (ed.). United kingdom: Future Medicine Ltd, p. 18-41

Research output: Chapter in Book/Conference paperChapter

2015
5 Citations (Scopus)

The hinterland of familial hypercholesterolaemia: what do we not know?

Wierzbicki, A. S. & Watts, G. F., Dec 2015, In : Current Opinion in Lipidology. 26, 6, p. 475-483 9 p.

Research output: Contribution to journalReview article

Hyperlipoproteinemia Type II
Guidelines
Epidemiology
Cardiovascular Diseases
Life Style
2016
16 Citations (Scopus)

Statin therapy and plasma free fatty acids: A systematic review and meta-analysis of controlled clinical trials

Sahebkar, A., Simental-Mendía, L. E., Pedone, C., Ferretti, G., Nachtigal, P., Bo, S., Derosa, G., Maffioli, P. & Watts, G. F., 2016, In : British Journal of Clinical Pharmacology. 81, 5, p. 807-818 12 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Controlled Clinical Trials
Nonesterified Fatty Acids
Meta-Analysis
Therapeutics
5 Citations (Scopus)

Europe aspires to set the record straight on familial hypercholesterolaemia

Watts, G. F., Pang, J. & Santos, R. D., 2016, In : Atherosclerosis. 241, 2, p. 769-771 3 p.

Research output: Contribution to journalLetter

2017
45 Citations (Scopus)

Factorial effects of evolocumab and atorvastatin on lipoprotein metabolism

Watts, G. F., Chan, D. C., Dent, R., Somaratne, R., Wasserman, S. M., Scott, R., Burrows, S. & Barrett, P. H. R., 24 Jan 2017, In : Circulation. 135, 4, p. 338-351 14 p.

Research output: Contribution to journalArticle

Apolipoprotein B-100
Lipoproteins
LDL Lipoproteins
IDL Lipoproteins
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2010

Updating the metabolism of apolipoprotein B-100 containing lipoproteins in dyslipidaemia

Watts, G., Chan, D. & Barrett, H., 2010, The Year In Lipid Disorders. Toth, P. P. (ed.). United Kingdom: Clinical Publishing Oxford, Vol. 2. p. 118-139

Research output: Chapter in Book/Conference paperChapter

2014
25 Citations (Scopus)

An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer

Mooranian, A., Negrulj, R., Chen-Tan, N. W., Watts, G., Arfuso, F. & Al-Salami, H., 2014, In : Drug Design, Development and Therapy. 8, p. 1673-1683

Research output: Contribution to journalArticle

Open Access
Probucol
Deoxycholic Acid
Bile Acids and Salts
Capsules
Excipients
2010
11 Citations (Scopus)

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome

Ng, T. W., Chan, D., Barrett, H. & Watts, G., 2010, In : Clinical Science. 118, p. 79-85

Research output: Contribution to journalArticle

Open Access
2015
67 Citations (Scopus)

Association between statin use and plasma d-dimer levels: A systematic review and meta-analysis of randomised controlled trials

Sahebkar, A., Serban, C., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., Muntner, P., Bittner, V., Ray, K. K., Watts, G., Hovingh, G. K., Rysz, J., Kastelein, J. J. P. & Banach, M., 2015, In : Thrombosis and Haemostasis. 114, 3, p. 546-557

Research output: Contribution to journalArticle

Simvastatin
Meta-Analysis
Randomized Controlled Trials
Confidence Intervals
Library Science
2014
18 Citations (Scopus)
212 Downloads (Pure)
Open Access
File
Apolipoprotein B-48
Plasmas
Kinetics
Metabolism
Area Under Curve
18 Citations (Scopus)

Detecting familial hypercholesterolaemia in the community: Impact of a telephone call from a chemical pathologist to the requesting general practitioner

Bell, D., Hooper, A., Edwards, G. A., Southwell, L., Pang, J., Van Bockxmeer, F., Watts, G. & Burnett, J., 2014, In : Atherosclerosis. 234, 2, p. 469-472

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Telephone
General Practitioners
Referral and Consultation
LDL Cholesterol
20 Citations (Scopus)

Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes

Mooranian, A., Negrulj, R., Al-Sallami, H. S., Fang, Z., Mikov, M. M., Goločorbin-Kon, S., Fakhoury, M., Watts, G., Matthews, V., Arfuso, F., Lambros, A. & Al-Salami, H., 2014, In : AAPS PharmSciTech. 16, 1, p. 45-52

Research output: Contribution to journalArticle

Open Access
probucol
Probucol
diabetes
alginate
noninsulin-dependent diabetes mellitus
2015
1 Citation (Scopus)

Clinical Guidelines on Hyperlipidaemia: Recent Developments, Future Challenges and the Need for an Australian Review

Sullivan, D. R., Watts, G., Nicholls, S. J., Barter, P., Grenfell, R., Chow, C. K., Tonkin, A. & Keech, A., 2015, In : Heart, Lung and Circulation. 24, 5, p. 495-502

Research output: Contribution to journalArticle

Hyperlipidemias
Guidelines
Cardiovascular Diseases
Lipids
American Heart Association
2016
9 Citations (Scopus)

Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Sahebkar, A., Simental-Mendía, L. E., Guerrero-Romero, F., Golledge, J. & Watts, G., 2016, In : Current Pharmaceutical Design. 22, 5, p. 595-608 14 p.

Research output: Contribution to journalArticle

evacetrapib
Lipid A
Meta-Analysis
Randomized Controlled Trials
Safety
2014
19 Citations (Scopus)

Statin myopathy: The fly in the ointment for the prevention of cardiovascular disease in the 21st century?

Keen, H., Krishnarajah, J., Bates, T. & Watts, G., 2014, In : Expert Opinion on Drug Safety. 13, 9, p. 1227-1239

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscular Diseases
Cardiovascular Diseases
Risk Management
Expert Testimony
2012
27 Citations (Scopus)

Screening for familial hypercholesterolaemia

Bender, R., Bell, D., Hooper, A., Edwards, G., Van Bockxmeer, F., Watts, G. & Burnett, J., 2012, In : Pathology. 44, 2, p. 122-128

Research output: Contribution to journalArticle

2011
18 Citations (Scopus)

Rosiglitazone does not improve vascular function in subjects with chronic kidney disease

Chan, D. T., Watts, G., Irish, A. & Dogra, G., 2011, In : Nephrology Dialysis Transplantation. 26, p. 3543–3549

Research output: Contribution to journalArticle

20 Citations (Scopus)
2013

An audit of pharmacists’ knowledge of familial hypercholesterolaemia: Implications for community healthcare

Jervis, L., Hanson, M., Bell, D., Krass, I. & Watts, G., 2013, In : Australian Pharmacist. July 2013, p. 73-75

Research output: Contribution to journalArticle

54 Citations (Scopus)

Demystifying the management of hypertriglyceridaemia

Watts, G., Ooi, E. & Chan, D., 2013, In : Nature Reviews Cardiology. 10, 11, p. 648-661

Research output: Contribution to journalReview article

Hypertriglyceridemia
Cardiovascular Diseases
Triglycerides
Lipoproteins
Hyperlipoproteinemia Type I
2012
14 Citations (Scopus)

A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology?

Watts, G., Sullivan, D. R., Van Bockxmeer, F., Poplawski, N., Hamilton-Craig, I., Clifton, P. M., O'Brien, R. C., Bishop, W., George, P. M., Semsarian, C. & Tonkin, A., 2012, In : Heart, Lung and Circulation. 21, p. 543-50

Research output: Contribution to journalArticle

14 Citations (Scopus)
2015
8 Citations (Scopus)

Evolocumab in the treatment of dyslipidemia: Pre-clinical and clinical pharmacology

Page, M. M. & Watts, G., 2015, In : Expert Opinion on Drug Metabolism & Toxicology. 11, 9, p. 1505-1515

Research output: Contribution to journalArticle

Clinical Pharmacology
Dyslipidemias
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Plasmas
Proprotein Convertases
2016
9 Citations (Scopus)
Open Access
Hyperlipoproteinemia Type II
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Screening
Medical education
Lipids
2010
18 Citations (Scopus)

A New Model of Care for Familial Hypercholesterolaemia from Western Australia: Closing a Major Gap in Preventive Cardiology

Watts, G., Van Bockxmeer, F., Bates, T., Burnett, J., Juniper, A. & O'Leary, P., 2010, In : Heart, Lung and Circulation. 19, p. 419-422

Research output: Contribution to journalArticle

2011
56 Citations (Scopus)
2017
Open Access
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Western Australia
Health Services
Economic Inflation
Health
2015
18 Citations (Scopus)

Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study

Fuentes, F., Alcala-Diaz, J. F., Watts, G., Alonso, R., Muñiz, O., Díaz-Díaz, J. L., Mata, N., Sanchez Muñoz-Torrero, J. F., Brea, Á., Galiana, J., Figueras, R., Aguado, R., Piedecausa, M., Cepeda, J. M., Vidal, J. I., Rodríguez-Cantalejo, F., López-Miranda, J. & Mata, P., 2015, In : International Journal of Cardiology. 201, p. 79-84

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemia Type II
Type 2 Diabetes Mellitus
Cohort Studies
Waist Circumference
2012
27 Citations (Scopus)
2016
8 Citations (Scopus)

Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: A creative approach by a cardiologist in a developing country

Khoo, K. L., Page, M. M., Liew, Y. M., Defesche, J. C. & Watts, G. F., 30 Sep 2016, In : Journal of Clinical Lipidology. 10, 5, p. 1188-1194 7 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Blood Component Removal
Malaysia
Developing Countries
Lipoproteins
2016
19 Citations (Scopus)
Hyperlipoproteinemia Type II
LDL Cholesterol
Lipoproteins
Genetic Testing
Therapeutics
2017
9 Citations (Scopus)

A Web-Based Registry for Familial Hypercholesterolaemia

Napier, K. R., Pang, J., Lamont, L., Walker, C. E., Dawkins, H. J., Hunter, A. A., Van Bockxmeer, F., Watts, G. F. & Bellgard, M. I., Jun 2017, In : Heart, Lung and Circulation. 26, 6, p. 635-639 5 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Registries
Australasia
Clinical Audit
New Zealand
2011
5 Citations (Scopus)
2013
19 Citations (Scopus)

Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells

Glineur, C., Gross, B. S., Neve, B. P., Rommens, C., Chew, G., Martin-Nizard, F., Rodríguez-Pascual, F., Lamas, S., Watts, G. & Staels, B., 2013, In : ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 33, 3, p. 621-628

Research output: Contribution to journalArticle

Open Access
Fenofibrate
Peroxisome Proliferator-Activated Receptors
Endothelin-1
Endothelial Cells
Glycogen Synthase Kinase 3
2014
40 Citations (Scopus)
Western Australia
Hyperlipoproteinemia Type II
General Practitioners
Primary Health Care
Cholesterol
2015
33 Citations (Scopus)
140 Downloads (Pure)
Open Access
File
Abetalipoproteinemia
Apolipoproteins B
Chylomicrons
Lipoproteins
Therapeutics
2013
69 Citations (Scopus)
Apolipoproteins B
Dyslipidemias
Hyperlipoproteinemia Type II
Hydroxymethylglutaryl-CoA Reductase Inhibitors
LDL Cholesterol
2015
72 Citations (Scopus)

Statin therapy and plasma coenzyme Q10 concentrations - A systematic review and meta-analysis of placebo-controlled trials

Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., Watts, G., Blumenthal, R. S., Lip, G. Y. H., Mikhailidis, D. P. & Sahebkar, A., 2015, In : Pharmacological Research. 99, p. 329-336

Research output: Contribution to journalArticle

coenzyme Q10
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Meta-Analysis
Placebos
Confidence Intervals
2017
4 Citations (Scopus)

Insulin resistance and vascular dysfunction in chronic kidney disease: Mechanisms and therapeutic interventions

Chan, D. T., Watts, G. F., Irish, A. B. & Dogra, G. K., Aug 2017, In : Nephrology, Dialysis, Transplantation. 32, 8, p. 1274–1281 8 p.

Research output: Contribution to journalLiterature review

Open Access
Chronic Renal Insufficiency
Blood Vessels
Insulin Resistance
Cardiovascular Diseases
Insulin
2014
11 Citations (Scopus)

Interrelationships between the kinetics of VLDL subspecies and hdl catabolism in abdominal obesity: A multicenter tracer kinetic study

Vergès, B. L., Adiels, M., Borén, J. B., Barrett, H., Watts, G., Chan, D., Duvillard, L., Söderlund, S., Matikainen, N., Kahri, J., Robin, I. & Taskinen, M. R., 2014, In : Journal of Clinical Endocrinology and Metabolism. 99, 11, p. 4281-4290

Research output: Contribution to journalArticle

Open Access
Abdominal Obesity
VLDL Lipoproteins
Apolipoprotein A-I
Kinetics
Triglycerides
2015
47 Citations (Scopus)
Coronary Care Units
Hyperlipoproteinemia Type II
Coronary Artery Disease
Lipids
Primary Prevention
2013
3 Citations (Scopus)